Tango Therapeutics, Inc. (TNGX) Revenue 2020–2025
Tango Therapeutics, Inc. (TNGX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$62.4MFY2025 · since FY2020: $7.7M → $62.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.4M | +48.3% |
| FY2024 | $42.1M | +15.2% |
| FY2023 | $36.5M | +46.9% |
| FY2022 | $24.9M | -32.9% |
| FY2021 | $37.0M | +383.8% |
| FY2020 | $7.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice